{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:06:20Z","timestamp":1777853180445,"version":"3.51.4"},"reference-count":16,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Int Assoc Provid AIDS Care"],"published-print":{"date-parts":[[2019,1,1]]},"abstract":"<jats:p>Non-nucleoside reverse-transcriptase inhibitor plus integrase strand transfer inhibitor\u2013based dual therapies are an attractive simplification, nucleoside reverse transcriptase inhibitor-sparing strategy for experienced human immunodeficiency virus-infected patients. Thus, we performed a 24-week real-life observational study to assess efficacy and safety of switching from raltegravir plus etravirine to dolutegravir plus rilpivirine in 7 previously heavily treated patients. This simplification strategy reduced pill burden and preserved viral suppression in treatment-experienced patients with no major mutations to rilpivirine at historical genotyping.<\/jats:p>","DOI":"10.1177\/2325958218821657","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T12:45:59Z","timestamp":1546951559000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["Maintenance of Viral Suppression after Optimization Therapy from Etravirine Plus Raltegravir to Rilpivirine Plus Dolutegravir in HIV-1-Infected Patients"],"prefix":"10.1177","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2947-4707","authenticated-orcid":false,"given":"Niccol\u00f2","family":"Riccardi","sequence":"first","affiliation":[{"name":"Infectious Diseases, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Del Puente","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6622-6358","authenticated-orcid":false,"given":"Lucia","family":"Taramasso","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Di Biagio","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Policlinico San Martino Hospital, Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2019,1,7]]},"reference":[{"key":"bibr1-2325958218821657","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12506"},{"key":"bibr2-2325958218821657","doi-asserted-by":"publisher","DOI":"10.2174\/1570162X113119990036"},{"key":"bibr3-2325958218821657","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2755-4"},{"key":"bibr4-2325958218821657","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164753"},{"key":"bibr5-2325958218821657","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt406"},{"key":"bibr6-2325958218821657","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.11.006"},{"key":"bibr7-2325958218821657","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2016.0291"},{"key":"bibr8-2325958218821657","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2016.07.009"},{"key":"bibr9-2325958218821657","doi-asserted-by":"publisher","DOI":"10.1177\/1060028017728294"},{"key":"bibr10-2325958218821657","volume-title":"Paper Presented at: Conference on Retroviruses and Opportunistic Infections","author":"Llibre JM"},{"key":"bibr11-2325958218821657","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001590"},{"key":"bibr12-2325958218821657","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2016.07.006"},{"key":"bibr13-2325958218821657","doi-asserted-by":"publisher","DOI":"10.2196\/med20.2712"},{"key":"bibr14-2325958218821657","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2017.0064"},{"key":"bibr15-2325958218821657","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkg100"},{"issue":"4","key":"bibr16-2325958218821657","first-page":"132","volume":"24","author":"Wensing AM","year":"2017","journal-title":"Top Antivir Med"}],"container-title":["Journal of the International Association of Providers of AIDS Care (JIAPAC)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2325958218821657","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2325958218821657","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2325958218821657","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:49:21Z","timestamp":1777502961000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2325958218821657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,1]]},"references-count":16,"alternative-id":["10.1177\/2325958218821657"],"URL":"https:\/\/doi.org\/10.1177\/2325958218821657","relation":{},"ISSN":["2325-9582","2325-9582"],"issn-type":[{"value":"2325-9582","type":"print"},{"value":"2325-9582","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,1]]},"article-number":"2325958218821657"}}